Home
TELA
TELA News

Latest TELA Bio Inc. (TELA) News on December 18, 2024

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

5 days ago

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

The past five years for TELA Bio (NASDAQ:TELA) investors has not been profitable

Simply Wall St.

17 days ago

The past five years for TELA Bio (NASDAQ:TELA) investors has not been profitable

TELA Bio to Participate in Piper Sandler’s 36th Annual Healthcare Conference

GlobeNewswire

a month ago

TELA Bio to Participate in Piper Sandler’s 36th Annual Healthcare Conference

TELA Bio Third Quarter 2024 Earnings: EPS Beats Expectations

Simply Wall St.

a month ago

TELA Bio Third Quarter 2024 Earnings: EPS Beats Expectations

Thomson Reuters StreetEvents

a month ago

Q3 2024 TELA Bio Inc Earnings Call

TELA Bio Inc (TELA) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

GuruFocus.com

a month ago

TELA Bio Inc (TELA) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

TELA Bio, Inc. (TELA) Reports Q3 Loss, Lags Revenue Estimates

Zacks

a month ago

TELA Bio, Inc. (TELA) Reports Q3 Loss, Lags Revenue Estimates

TELA Bio Reports Third Quarter 2024 Financial Results

GlobeNewswire

a month ago

TELA Bio Reports Third Quarter 2024 Financial Results

What To Expect From TELA Bio Inc (TELA) Q3 2024 Earnings

GuruFocus.com

a month ago

What To Expect From TELA Bio Inc (TELA) Q3 2024 Earnings

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

2 months ago

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

US Penny Stocks To Watch In October 2024

Simply Wall St.

2 months ago

US Penny Stocks To Watch In October 2024

Antony Koblish Bought 42% More Shares In TELA Bio

Simply Wall St.

2 months ago

Antony Koblish Bought 42% More Shares In TELA Bio

OrbiMed Advisors LLC Reduces Stake in TELA Bio Inc

GuruFocus.com

2 months ago

OrbiMed Advisors LLC Reduces Stake in TELA Bio Inc

TELA Bio Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

GlobeNewswire

2 months ago

TELA Bio Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

TELA Bio Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

GlobeNewswire

2 months ago

TELA Bio Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

TELA Bio Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

GlobeNewswire

2 months ago

TELA Bio Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

TELA Bio to Announce Third Quarter 2024 Financial Results

GlobeNewswire

2 months ago

TELA Bio to Announce Third Quarter 2024 Financial Results

Orbimed Advisors LLC Reduces Stake in TELA Bio Inc

GuruFocus.com

3 months ago

Orbimed Advisors LLC Reduces Stake in TELA Bio Inc

Zai Lab Limited (ZLAB) Surges 11.1%: Is This an Indication of Further Gains?

Zacks

3 months ago

Zai Lab Limited (ZLAB) Surges 11.1%: Is This an Indication of Further Gains?

TELA Bio Second Quarter 2024 Earnings: Misses Expectations

Simply Wall St.

4 months ago

TELA Bio Second Quarter 2024 Earnings: Misses Expectations

TELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue Estimates

Zacks

4 months ago

TELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue Estimates

TELA Bio Reports Second Quarter 2024 Financial Results and Reiterates Full Year 2024 Revenue Guidance

GlobeNewswire

4 months ago

TELA Bio Reports Second Quarter 2024 Financial Results and Reiterates Full Year 2024 Revenue Guidance

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

4 months ago

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Artivion (AORT) Surpasses Q2 Earnings and Revenue Estimates

Zacks

4 months ago

Artivion (AORT) Surpasses Q2 Earnings and Revenue Estimates

TELA Bio, Inc. (NASDAQ:TELA) has caught the attention of institutional investors who hold a sizeable 42% stake

Simply Wall St.

5 months ago

TELA Bio, Inc. (NASDAQ:TELA) has caught the attention of institutional investors who hold a sizeable 42% stake

TELA Bio to Participate in the Canaccord Genuity 44th Annual Growth Conference

GlobeNewswire

5 months ago

TELA Bio to Participate in the Canaccord Genuity 44th Annual Growth Conference

TELA Bio to Announce Second Quarter 2024 Financial Results

GlobeNewswire

5 months ago

TELA Bio to Announce Second Quarter 2024 Financial Results

Spirit Airlines not considering Chapter 11 bankruptcy, CNBC reports

Reuters

6 months ago

Spirit Airlines not considering Chapter 11 bankruptcy, CNBC reports

DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio

Newsfile

6 months ago

DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio

BW Energy: Mandatory notifications of trade by primary insiders and close associates

GlobeNewswire

6 months ago

BW Energy: Mandatory notifications of trade by primary insiders and close associates

Aqua-Tots Swim School Splashes Into Summer With Highly-Anticipated Grand Opening in Henderson, Nevada

GlobeNewswire

6 months ago

Aqua-Tots Swim School Splashes Into Summer With Highly-Anticipated Grand Opening in Henderson, Nevada

Sage Potash Grants Stock Options

CNW Group

6 months ago

Sage Potash Grants Stock Options

Moderna Files FDA Application for the JN.1 Targeting COVID-19 Vaccine

ACCESSWIRE

6 months ago

Moderna Files FDA Application for the JN.1 Targeting COVID-19 Vaccine

AllianceBernstein: Office Space: Looking Past the Doom and Gloom

ACCESSWIRE

6 months ago

AllianceBernstein: Office Space: Looking Past the Doom and Gloom

Decisions of the Ordinary General Shareholders' Meeting of Novaturas AB

GlobeNewswire

6 months ago

Decisions of the Ordinary General Shareholders' Meeting of Novaturas AB

TELA Bio Appoints Jeffrey Blizard to its Board of Directors

GlobeNewswire

6 months ago

TELA Bio Appoints Jeffrey Blizard to its Board of Directors

TELA Bio Appoints Greg Firestone as Chief Commercial Officer

GlobeNewswire

7 months ago

TELA Bio Appoints Greg Firestone as Chief Commercial Officer

TELA Bio, Inc. (NASDAQ:TELA) Q1 2024 Earnings Call Transcript

Insider Monkey

7 months ago

TELA Bio, Inc. (NASDAQ:TELA) Q1 2024 Earnings Call Transcript

TELA Bio First Quarter 2024 Earnings: US$0.23 loss per share (vs US$0.63 loss in 1Q 2023)

Simply Wall St.

7 months ago

TELA Bio First Quarter 2024 Earnings: US$0.23 loss per share (vs US$0.63 loss in 1Q 2023)

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

7 months ago

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GuruFocus.com

7 months ago

TELA Bio Inc (TELA) Reports Q1 2024 Earnings: Revenue Surpasses Estimates Amidst Continued Growth

MT Newswires

7 months ago

Piper Sandler Adjusts Price Target on TELA Bio to $10 From $12, Maintains Overweight Rating

TELA Bio Reports First Quarter 2024 Financial Results

GlobeNewswire

7 months ago

TELA Bio Reports First Quarter 2024 Financial Results

TELA Bio to Announce First Quarter 2024 Financial Results

GlobeNewswire

8 months ago

TELA Bio to Announce First Quarter 2024 Financial Results

TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex® IHR – Addressing the Need for a More Natural Repair in Inguinal Hernia Procedures

GlobeNewswire

8 months ago

TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex® IHR – Addressing the Need for a More Natural Repair in Inguinal Hernia Procedures

Syros Pharmaceuticals (SYRS) Soars 22.2%: Is Further Upside Left in the Stock?

Zacks

8 months ago

Syros Pharmaceuticals (SYRS) Soars 22.2%: Is Further Upside Left in the Stock?

TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon Strategy

GlobeNewswire

8 months ago

TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon Strategy

Analysts Are Updating Their TELA Bio, Inc. (NASDAQ:TELA) Estimates After Its Full-Year Results

Simply Wall St.

9 months ago

Analysts Are Updating Their TELA Bio, Inc. (NASDAQ:TELA) Estimates After Its Full-Year Results

TELA Bio Full Year 2023 Earnings: US$2.04 loss per share (vs US$2.72 loss in FY 2022)

Simply Wall St.

9 months ago

TELA Bio Full Year 2023 Earnings: US$2.04 loss per share (vs US$2.72 loss in FY 2022)

TELA Bio, Inc. (NASDAQ:TELA) Q4 2023 Earnings Call Transcript

Insider Monkey

9 months ago

TELA Bio, Inc. (NASDAQ:TELA) Q4 2023 Earnings Call Transcript

Thomson Reuters StreetEvents

9 months ago

Q4 2023 TELA Bio Inc Earnings Call

TELA Bio Inc Reports Robust Revenue Growth in Q4 and Full Year 2023

GuruFocus.com

9 months ago

TELA Bio Inc Reports Robust Revenue Growth in Q4 and Full Year 2023

TELA Bio, Inc. (TELA) Reports Q4 Loss, Tops Revenue Estimates

Zacks

9 months ago

TELA Bio, Inc. (TELA) Reports Q4 Loss, Tops Revenue Estimates

TELA Bio Achieves Record Fourth Quarter and Full Year 2023 Revenues and Reports Complete Financial Results

GlobeNewswire

9 months ago

TELA Bio Achieves Record Fourth Quarter and Full Year 2023 Revenues and Reports Complete Financial Results

TELA Bio Announces U.S. Commercial Launch of LIQUIFIX™ – the Only FDA-Approved Liquid Adhesive for Internal Use in Hernia Surgery

GlobeNewswire

9 months ago

TELA Bio Announces U.S. Commercial Launch of LIQUIFIX™ – the Only FDA-Approved Liquid Adhesive for Internal Use in Hernia Surgery

MIMEDX Expands Portfolio with Fibrillar Collagen Wound Dressing

GlobeNewswire

9 months ago

MIMEDX Expands Portfolio with Fibrillar Collagen Wound Dressing

TELA Bio Announces Sale of Distribution Rights for Wound Care Product to MIMEDX

GlobeNewswire

9 months ago

TELA Bio Announces Sale of Distribution Rights for Wound Care Product to MIMEDX

TELA Bio to Announce Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire

10 months ago

TELA Bio to Announce Fourth Quarter and Full Year 2023 Financial Results

Wave Life Sciences (WVE) Surges 10.9%: Is This an Indication of Further Gains?

Zacks

10 months ago

Wave Life Sciences (WVE) Surges 10.9%: Is This an Indication of Further Gains?

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

10 months ago

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

With 54% institutional ownership, TELA Bio, Inc. (NASDAQ:TELA) is a favorite amongst the big guns

Simply Wall St.

10 months ago

With 54% institutional ownership, TELA Bio, Inc. (NASDAQ:TELA) is a favorite amongst the big guns

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

TScan Therapeutics Announces Best Abstracts Award and Upcoming Oral Presentation at the 2024 Tandem Meetings of ASTCT and CIBMTR

GlobeNewswire

a year ago

TScan Therapeutics Announces Best Abstracts Award and Upcoming Oral Presentation at the 2024 Tandem Meetings of ASTCT and CIBMTR

3 Pot Stocks to Avoid Like the Plague in 2024

Motley Fool

a year ago

3 Pot Stocks to Avoid Like the Plague in 2024

GuruFocus.com

a year ago

NVE Corp (NVEC) Reports Decrease in Q3 Revenue and Net Income, Maintains Dividend

Associated Press Finance

a year ago

NVE: Fiscal Q3 Earnings Snapshot

NVE Corporation Reports Third Quarter Results and Announces Quarterly Dividend

GlobeNewswire

a year ago

NVE Corporation Reports Third Quarter Results and Announces Quarterly Dividend

TELA Bio to Take Part in Connecting the Dots

GlobeNewswire

a year ago

TELA Bio to Take Part in Connecting the Dots

7 ‘Turkey’ Stocks to Pluck from Your Portfolio BEFORE Thanksgiving

InvestorPlace

a year ago

7 ‘Turkey’ Stocks to Pluck from Your Portfolio BEFORE Thanksgiving

TELA Bio to Participate in Piper Sandler’s 35th Annual Healthcare Conference

GlobeNewswire

a year ago

TELA Bio to Participate in Piper Sandler’s 35th Annual Healthcare Conference

TELA Bio, Inc. (NASDAQ:TELA) Q3 2023 Earnings Call Transcript

Insider Monkey

a year ago

TELA Bio, Inc. (NASDAQ:TELA) Q3 2023 Earnings Call Transcript

TELA Bio Reports Third Quarter 2023 Financial Results

GlobeNewswire

a year ago

TELA Bio Reports Third Quarter 2023 Financial Results

Share on Social Networks: